Avenue Therapeutics Ownership 2024 | Who Owns Avenue Therapeutics Now?

Overview ForecastFinancials Chart

Institutional Ownership

1.12%

Insider Ownership

1.25%

Retail Ownership

97.63%

Institutional Holders

1.00

Avenue Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SHIKIAR ASSET MANAGEMENT INC	-	-	-	-25,000	-100.00%	-	Sep 30, 2023

Avenue Therapeutics's largest institutional shareholder is SHIKIAR ASSET MANAGEMENT INC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SHIKIAR ASSET MANAGEMENT INC	-	-	-	-25,000	-100.00%	-	Sep 30, 2023

The largest Avenue Therapeutics shareholder by % of total assets is SHIKIAR ASSET MANAGEMENT INC. The company owns 0.00 shares of Avenue Therapeutics (ATXI), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SHIKIAR ASSET MANAGEMENT INC	-	-	-	-25,000	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Avenue Therapeutics's largest institutional buyer is SHIKIAR ASSET MANAGEMENT INC. The company purchased -25.00K stocks of ATXI, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SHIKIAR ASSET MANAGEMENT INC	-	-	-	-25,000	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Avenue Therapeutics's biggest institutional seller is SHIKIAR ASSET MANAGEMENT INC. The company sold -25.00K shares of ATXI, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SHIKIAR ASSET MANAGEMENT INC	-	-	-	-25,000	-100.00%	-	Sep 30, 2023

Avenue Therapeutics's largest sold out institutional shareholder by shares sold is SHIKIAR ASSET MANAGEMENT INC, sold -25.00K shares, valued at -, as of undefined.

Avenue Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY COMMONWEALTH TRUST	0.00%	10,099	-	-	Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.00%	1,234	-	-	Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC	0.00%	10,559	-	-	Mar 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST	0.00%	6,672	-	-	Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 1	0.00%	340	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	82,446	-	-	Feb 29, 2024
SCHWAB CAPITAL TRUST	0.00%	14,314	-	-	Feb 29, 2024
GPS Funds I	0.00%	1,826	-	-	Mar 31, 2024
TIAA-CREF LIFE FUNDS	0.00%	913	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	125,030	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	52,160	-411	-0.78%	Feb 29, 2024
Calvert Variable Products, Inc.	0.00%	589	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	46,293	-46,293	-50.00%	Mar 31, 2024
SunAmerica Specialty Series	0.00%	55	-	-	Apr 30, 2021
HC CAPITAL TRUST	0.00%	1,895	-	-	Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	1,400	-	-	Mar 31, 2024
RUSSELL INVESTMENT CO	0.00%	12,160	-	-	Jan 31, 2024
Investment Managers Series Trust II	0.00%	473	-	-	Jan 31, 2024
NORTHERN FUNDS	0.00%	3,845	-	-	Mar 28, 2024
PGIM ETF TRUST	0.00%	1,588	-	-	Feb 29, 2024
OLD WESTBURY FUNDS INC	0.00%	3,118	-	-	Jan 31, 2024
FIDELITY SALEM STREET TRUST	0.00%	85,030	-	-	Mar 31, 2024
Goldman Sachs ETF Trust	0.00%	1,697	-	-	Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	1,000	-	-	Mar 31, 2024
ProFunds	0.00%	144	-	-	Mar 31, 2024
MAINSTAY VP FUNDS TRUST	0.00%	1,400	-	-	Mar 31, 2024
VALIC Co I	0.00%	3,163	-	-	Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	21,184	-	-	Feb 29, 2024
TIAA-CREF FUNDS	0.00%	29,376	-	-	Mar 31, 2024
ALLSPRING MASTER TRUST	0.00%	491	-	-	Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	993	-	-	Mar 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	852	-	-	Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND	0.00%	5,456	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	1,162	-	-	Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	421	-	-	Feb 29, 2024
T. Rowe Price Index Trust, Inc.	0.00%	59	-	-	Feb 29, 2024
SUNAMERICA SERIES TRUST	0.00%	721	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	1,678	-	-	Mar 31, 2024
MAINSTAY FUNDS TRUST	0.00%	200	-	-	Jan 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	975	-	-	Dec 31, 2023
PACIFIC SELECT FUND	0.00%	2,937	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	7,710	-	-	Mar 31, 2024
Bridge Builder Trust	0.00%	2,010	-	-	Mar 31, 2024
BlackRock Variable Series Funds, Inc.	0.00%	806	-	-	Mar 31, 2024
PRINCIPAL FUNDS, INC.	0.00%	821	-	-	Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	250	-	-	Mar 31, 2024

Avenue Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 10.10K shares, compromising 0.00% of its total assets.

Avenue Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 23	1	-
31 Mar, 23	1	-
30 Jun, 22	16	14.29%
31 Mar, 22	14	-6.67%
31 Dec, 21	15	-16.67%
30 Sep, 21	18	-28.00%
30 Jun, 21	25	-26.47%
31 Mar, 21	34	-2.86%
31 Dec, 20	35	6.06%
30 Sep, 20	33	-8.33%
30 Jun, 20	36	80.00%
31 Mar, 20	20	33.33%
31 Dec, 19	15	-
30 Sep, 19	15	25.00%
30 Jun, 19	12	-7.69%
31 Mar, 19	13	85.71%
31 Dec, 18	7	-
30 Sep, 18	7	-
30 Jun, 18	7	40.00%
31 Mar, 18	5	-
31 Dec, 17	5	-37.50%
30 Sep, 17	8	300.00%
30 Jun, 17	2	-

As of 30 Jun 23, 1 institutions are holding Avenue Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 23	25,000	-37.49%
31 Mar, 23	39,992	-
30 Jun, 22	673,937	-35.25%
31 Mar, 22	1,040,903	-55.93%
31 Dec, 21	2,361,894	116.90%
30 Sep, 21	1,088,937	-5.29%
30 Jun, 21	1,149,746	-37.70%
31 Mar, 21	1,845,619	-10.20%
31 Dec, 20	2,055,305	-25.11%
30 Sep, 20	2,744,268	5.03%
30 Jun, 20	2,612,751	33.02%
31 Mar, 20	1,964,145	25.08%
31 Dec, 19	1,570,283	8.09%
30 Sep, 19	1,452,790	6.54%
30 Jun, 19	1,363,573	17.61%
31 Mar, 19	1,159,432	68.47%
31 Dec, 18	688,200	212.33%
30 Sep, 18	220,347	-0.01%
30 Jun, 18	220,363	11.61%
31 Mar, 18	197,434	38.61%
31 Dec, 17	142,439	2.28%
30 Sep, 17	139,259	387.09%
30 Jun, 17	28,590	-

Avenue Therapeutics (ATXI) has 25.00K shares outstanding as of 30 Jun 23, down -37.49% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 23	1.12%	34.79%
31 Mar, 23	1.80%	-
30 Jun, 22	3.08%	12.46%
31 Mar, 22	4.97%	2.44%
31 Dec, 21	14.27%	33.26%
30 Sep, 21	6.55%	13.58%
30 Jun, 21	6.94%	5.59%
31 Mar, 21	11.15%	7.23%
31 Dec, 20	12.41%	4.50%
30 Sep, 20	16.61%	6.60%
30 Jun, 20	15.86%	11.16%
31 Mar, 20	11.92%	13.12%
31 Dec, 19	9.53%	12.11%
30 Sep, 19	8.87%	12.70%
30 Jun, 19	8.36%	11.74%
31 Mar, 19	8.44%	18.67%
31 Dec, 18	6.72%	146.75%
30 Sep, 18	2.14%	46.32%
30 Jun, 18	2.15%	56.24%
31 Mar, 18	1.95%	95.74%
31 Dec, 17	1.43%	73.21%
30 Sep, 17	1.40%	204.60%
30 Jun, 17	0.83%	-

As of 30 Jun 23, Avenue Therapeutics is held by 1.12% institutional shareholders, representing a 34.79% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 23	1	-
31 Mar, 23	1	-
30 Jun, 22	6	-25.00%
31 Mar, 22	8	14.29%
31 Dec, 21	7	-22.22%
30 Sep, 21	9	-30.77%
30 Jun, 21	13	-13.33%
31 Mar, 21	15	-31.82%
31 Dec, 20	22	46.67%
30 Sep, 20	15	-51.61%
30 Jun, 20	31	93.75%
31 Mar, 20	16	77.78%
31 Dec, 19	9	12.50%
30 Sep, 19	8	33.33%
30 Jun, 19	6	-33.33%
31 Mar, 19	9	125.00%
31 Dec, 18	4	33.33%
30 Sep, 18	3	-40.00%
30 Jun, 18	5	66.67%
31 Mar, 18	3	-40.00%
31 Dec, 17	5	-28.57%
30 Sep, 17	7	250.00%
30 Jun, 17	2	-

1 institutional shareholders have increased their position in ATXI stock as of 30 Jun 23 compared to 1 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 23	-	-
31 Mar, 23	-	-
30 Jun, 22	7	133.33%
31 Mar, 22	3	-40.00%
31 Dec, 21	5	-
30 Sep, 21	5	-54.55%
30 Jun, 21	11	22.22%
31 Mar, 21	9	50.00%
31 Dec, 20	6	-53.85%
30 Sep, 20	13	550.00%
30 Jun, 20	2	100.00%
31 Mar, 20	1	-75.00%
31 Dec, 19	4	-
30 Sep, 19	4	33.33%
30 Jun, 19	3	50.00%
31 Mar, 19	2	-
31 Dec, 18	2	-
30 Sep, 18	2	100.00%
30 Jun, 18	1	-50.00%
31 Mar, 18	2	-
31 Dec, 17	-	-100.00%
30 Sep, 17	1	-
30 Jun, 17	-	-

- institutional shareholders have reduced their position in ATXI stock as of 30 Jun 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 23	1	-	25,000	-37.49%	1.12%	34.79%	1	-	-	-
31 Mar, 23	1	-	39,992	-	1.80%	-	1	-	-	-
30 Jun, 22	16	14.29%	673,937	-35.25%	3.08%	12.46%	6	-25.00%	7	133.33%
31 Mar, 22	14	-6.67%	1,040,903	-55.93%	4.97%	2.44%	8	14.29%	3	-40.00%
31 Dec, 21	15	-16.67%	2,361,894	116.90%	14.27%	33.26%	7	-22.22%	5	-
30 Sep, 21	18	-28.00%	1,088,937	-5.29%	6.55%	13.58%	9	-30.77%	5	-54.55%
30 Jun, 21	25	-26.47%	1,149,746	-37.70%	6.94%	5.59%	13	-13.33%	11	22.22%
31 Mar, 21	34	-2.86%	1,845,619	-10.20%	11.15%	7.23%	15	-31.82%	9	50.00%
31 Dec, 20	35	6.06%	2,055,305	-25.11%	12.41%	4.50%	22	46.67%	6	-53.85%
30 Sep, 20	33	-8.33%	2,744,268	5.03%	16.61%	6.60%	15	-51.61%	13	550.00%
30 Jun, 20	36	80.00%	2,612,751	33.02%	15.86%	11.16%	31	93.75%	2	100.00%
31 Mar, 20	20	33.33%	1,964,145	25.08%	11.92%	13.12%	16	77.78%	1	-75.00%
31 Dec, 19	15	-	1,570,283	8.09%	9.53%	12.11%	9	12.50%	4	-
30 Sep, 19	15	25.00%	1,452,790	6.54%	8.87%	12.70%	8	33.33%	4	33.33%
30 Jun, 19	12	-7.69%	1,363,573	17.61%	8.36%	11.74%	6	-33.33%	3	50.00%
31 Mar, 19	13	85.71%	1,159,432	68.47%	8.44%	18.67%	9	125.00%	2	-
31 Dec, 18	7	-	688,200	212.33%	6.72%	146.75%	4	33.33%	2	-
30 Sep, 18	7	-	220,347	-0.01%	2.14%	46.32%	3	-40.00%	2	100.00%
30 Jun, 18	7	40.00%	220,363	11.61%	2.15%	56.24%	5	66.67%	1	-50.00%
31 Mar, 18	5	-	197,434	38.61%	1.95%	95.74%	3	-40.00%	2	-
31 Dec, 17	5	-37.50%	142,439	2.28%	1.43%	73.21%	5	-28.57%	-	-100.00%
30 Sep, 17	8	300.00%	139,259	387.09%	1.40%	204.60%	7	250.00%	1	-
30 Jun, 17	2	-	28,590	-	0.83%	-	2	-	-	-

Avenue Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	264,000	$0.14	$36.96K	681,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	126,000	$0.14	$17.64K	215,800
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	128,000	$0.14	$17.92K	147,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	20,000	$0.14	$2.80K	80,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	61,000	$0.14	$8.54K	74,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	18,000	$0.15	$2.70K	22,000
Sep 12, 2023	ROSENWALD LINDSAY A MD	director	-	P-Purchase	Buy	348,675	$0.72	$251.05K	354,318
Sep 12, 2023	Fortress Biotech, Inc.	10 percent owner	-	P-Purchase	Buy	418,410	$0.72	$301.26K	1,032,390

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 12, 2023	ROSENWALD LINDSAY A MD	director	-	P-Purchase	Buy	348,675	$0.72	$251.05K	354,318
Sep 12, 2023	Fortress Biotech, Inc.	10 percent owner	-	P-Purchase	Buy	418,410	$0.72	$301.26K	1,032,390

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	264,000	$0.14	$36.96K	681,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	126,000	$0.14	$17.64K	215,800
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	128,000	$0.14	$17.92K	147,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	20,000	$0.14	$2.80K	80,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	61,000	$0.14	$8.54K	74,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	18,000	$0.15	$2.70K	22,000
Nov 28, 2023	Davidow Robert L	10 percent owner	-		Sell	-	-	-	945,000

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 17, 2024	Fortress Biotech, Inc.	10 percent owner	-	A-Award	Buy	413,507	-	-	3,547,393
Jan 03, 2024	Fortress Biotech, Inc.	10 percent owner	-	A-Award	Buy	2,101,496	-	-	3,133,886
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	264,000	$0.14	$36.96K	681,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	126,000	$0.14	$17.64K	215,800
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	128,000	$0.14	$17.92K	147,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	20,000	$0.14	$2.80K	80,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	61,000	$0.14	$8.54K	74,000
Dec 13, 2023	Davidow Robert L	10 percent owner	-	S-Sale	Sell	18,000	$0.15	$2.70K	22,000
Nov 28, 2023	Davidow Robert L	10 percent owner	-		Sell	-	-	-	945,000
Nov 28, 2023	Davidow Robert L	10 percent owner	-		Buy	-	-	-	341,800
Nov 28, 2023	Davidow Robert L	10 percent owner	-		Buy	-	-	-	275,000
Nov 28, 2023	Davidow Robert L	10 percent owner	-		Buy	-	-	-	135,000
Nov 28, 2023	Davidow Robert L	10 percent owner	-		Buy	-	-	-	100,000
Nov 28, 2023	Davidow Robert L	10 percent owner	-		Buy	-	-	-	90,000
Nov 28, 2023	Davidow Robert L	10 percent owner	-		Buy	-	-	-	40,000
Sep 12, 2023	ROSENWALD LINDSAY A MD	director	-	P-Purchase	Buy	348,675	$0.72	$251.05K	354,318
Sep 12, 2023	Fortress Biotech, Inc.	10 percent owner	-	P-Purchase	Buy	418,410	$0.72	$301.26K	1,032,390
Jul 05, 2023	Charles Faith L.	director	-	A-Award	Buy	100,000	$1.14	$114.00K	100,000
Jul 05, 2023	Jin David	officer	Interim PFO and COO	A-Award	Buy	250,000	$1.14	$285.00K	250,000
Jul 05, 2023	ROSENWALD LINDSAY A MD	director	-	A-Award	Buy	100,000	$1.14	$114.00K	100,000

The last insider sell of Avenue Therapeutics's stock was made by Davidow Robert L on Dec 13 2023, selling 264,000 shares at $0.14 per share (valued at $36.96K). The last insider buy of ATXI was made by ROSENWALD LINDSAY A MD on Sep 12 2023, buying 348,675 shares at $0.72 per share (worth $251.05K).

Avenue Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	1	-	-
Q1 2024	1	-	-
Q4 2023	-	7	-
Q3 2023	2	-	-
Q2 2023	7	-	-
Q1 2023	2	-	-
Q4 2022	1	1	100.00%
Q3 2022	-	-	-
Q2 2022	-	-	-
Q4 2021	7	-	-
Q3 2021	-	1	-
Q2 2021	1	-	-
Q3 2020	-	1	-
Q2 2020	2	-	-
Q1 2020	9	-	-
Q3 2019	3	2	150.00%
Q2 2019	5	-	-
Q1 2019	8	1	800.00%
Q4 2018	2	-	-
Q3 2018	9	-	-

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Avenue Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	-	6	-
Q3 2023	2	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	1	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	-	1	-
Q2 2021	1	-	-
Q3 2020	-	1	-
Q2 2020	-	-	-
Q1 2020	7	-	-
Q3 2019	1	2	50.00%
Q2 2019	3	-	-
Q1 2019	8	-	-
Q4 2018	2	-	-
Q3 2018	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Avenue Therapeutics's stocks.

Avenue Therapeutics Peer Ownership

Ticker	Company
BDRX	Biodexa Pharmaceuticals Plc
HOTH	Hoth Therapeutics, Inc.
CFRX	ContraFect Corporation
CNSP	CNS Pharmaceuticals, Inc.
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
VRAX	Virax Biolabs Group Limited
ALLR	Allarity Therapeutics, Inc.
NRBO	NeuroBo Pharmaceuticals, Inc.
WINT	Windtree Therapeutics, Inc.
PALI	Palisade Bio, Inc.

ATXI Ownership FAQ

Who Owns Avenue Therapeutics?

Avenue Therapeutics is owned by institutional shareholders (1.12%), insiders (1.25%), and public (97.63%). The largest institutional shareholder of Avenue Therapeutics is SHIKIAR ASSET MANAGEMENT INC (0% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.00% of total shares).

Who are the major institutional shareholders of Avenue Therapeutics?

Avenue Therapeutics's major institutional shareholders are SHIKIAR ASSET MANAGEMENT INC. The top five shareholders own together 0% of the company's share outstanding.

How many Avenue Therapeutics shareholders are there?

As of Jun 2023, there are 1 institutional shareholders of Avenue Therapeutics.

What percentage of Avenue Therapeutics is owned by SHIKIAR ASSET MANAGEMENT INC?

SHIKIAR ASSET MANAGEMENT INC owns 0 shares of Avenue Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).